Clinical Trial Update: Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting

View source ↗

Summary

An observational clinical trial to assess long-term use of pegunigalsidase alfa in Fabry disease patients in real-world settings; the study is NOT_YET_RECRUITIN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Pegunigalsidase alfa (pegunigalsidase alfa)

Snippet

Sponsor: Chiesi Italia | Conditions: Fabry Disease | Status: NOT_YET_RECRUITING